US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Neuroscience and Healthcare ETF

35.19

-1.3627-3.73%

Post-market: 35.190.00000.00%16:10 EDT

Volume:817

Turnover:29.18K

Market Cap:7.04M

PE:- -

High:36.34

Open:36.34

Low:35.19

Close:36.55

52wk High:43.01

52wk Low:25.98

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.34

T/O Rate:0.41%

Dividend:0.32

Dividend Rate:0.91%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Scholar Rock Grants Inducement Equity Awards for 51,947 Shares to 12 New Hires

Scholar Rock Reports New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Amex Halt Add Info Lst 43.010000

THOMSON REUTERS

Xenon Pharmaceuticals Director Steven Gannon Disposes of 10,000 Common Shares for $640,550

Scholar Rock Holding Price Target Raised to $63.00/Share from $56.00 by JP Morgan

BofA Securities Boosts Targets on Chinese CXO Players as Strong Biotech Funding Fuels R&D

Bank of America Securities Raises Targets for Chinese CXO Firms on Strong Biotech Funding

Alkermes Cuts Interest Spreads on $1.52 Billion Term Loan Facilities Via Credit Agreement Amendment

Alkermes - Enters Amendment No. 1 to Credit Agreement on August 12, 2026 - SEC Filing

THOMSON REUTERS

Alkermes - Amendment Reduces Interest Rate Spread Under Tla by 0.75% and Tlb by 0.50% - SEC Filing

THOMSON REUTERS

Jiangxi Party Chief Inspects Ganjiang New Area, Urges Accelerated Industry Transformation and New Growth Drivers

Yin Hong Inspects Ganjiang New Area: Striving to Seize New Industrial Frontiers, Forge New Growth Drivers, and Demonstrate Excellence

PICC P&C Issues China's First Invasive Brain-Computer Interface Surgery Accident Insurance

Dianthus Therapeutics SVP General Counsel Adam Veness Melepas Saham Senilai USD 2,21 Juta

J.P. Morgan Remains a Buy on Xenon (XENE)

Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), Elanco Animal Health (ELAN)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)

Scholar Rock Holding Price Target Maintained with a $65.00/Share by HC Wainwright & Co.

Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Relay Therapeutics (RLAY) and Amylyx Pharmaceuticals Inc (AMLX)

Update: Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/IBRN/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":35.19,"timestamp":1789761600000,"preClose":36.5527,"halted":0,"volume":817,"hourTrading":{"tag":"盘后","latestPrice":35.19,"preClose":35.19,"latestTime":"16:10 EDT","volume":6,"amount":211.14,"timestamp":1789762203991,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03728041977747208,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"Market Closed","change":-1.3627,"latestTime":"09-18 16:00:00 EDT","open":36.34,"high":36.34,"low":35.19,"amount":29180,"amplitude":0.031461,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":36.5527,"sharesOutstanding":150000,"nav":36.582813,"aum":7316562.6,"dividendRate":0.009142,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.19,"preClose":35.19,"latestTime":"16:10 EDT","volume":6,"amount":211.14,"timestamp":1789762203991,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.33610331419301065,"impliedVol":0.0187,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.33610331419301065,"shares":200000,"dividePrice":0.3217,"high":36.34,"amplitude":0.031461,"preClose":36.5527,"low":35.19,"week52Low":25.98,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":35.19,"eps":0,"divideRate":0.009142,"volume":817,"delay":0,"ttmEps":0,"open":36.34,"prevYearClose":32.3193,"prevWeekClose":37.4262,"prevMonthClose":38.9601,"prevQuarterClose":38.8263,"fiveDayClose":37.4262,"twentyDayClose":39.3798,"sixtyDayClose":37.3173},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659129349","title":"Scholar Rock Grants Inducement Equity Awards for 51,947 Shares to 12 New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129349","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129349?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:15","pubTimestamp":1786738521,"startTime":"0","endTime":"0","summary":"Scholar Rock grants inducement equity awards for 51,947 shares to 12 new hiresScholar Rock granted inducement equity awards covering 51,947 common shares to 12 newly hired employees under its 2022 Ind","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL6LXLYl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SRRK","IBRN","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659293951","title":"Scholar Rock Reports New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659293951","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659293951?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:15","pubTimestamp":1786738500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA31SSFM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","THNR","SRRK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659714295","title":"Amex Halt Add Info Lst 43.010000","url":"https://stock-news.laohu8.com/highlight/detail?id=2659714295","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659714295?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:47","pubTimestamp":1786715258,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nAQN2MESOH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160360","title":"Xenon Pharmaceuticals Director Steven Gannon Disposes of 10,000 Common Shares for $640,550","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160360","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160360?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:42","pubTimestamp":1786653738,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals director Steven Gannon disposes of 10,000 common shares for $640,550Xenon Pharmaceuticals director Steven Gannon sold 10,000 common shares on Aug. 11, 2026 at a weighted-average ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1zKHrZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Xenon Pharmaceuticals Director Steven Gannon Disposes of 10,000 Common Shares for $640,550","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","XENE","SBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659517165","title":"Scholar Rock Holding Price Target Raised to $63.00/Share from $56.00 by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2659517165","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659517165?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:19","pubTimestamp":1786634340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SRRK/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SRRK","IBRN","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155684243","title":"BofA Securities Boosts Targets on Chinese CXO Players as Strong Biotech Funding Fuels R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=1155684243","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155684243?lang=en_us&edition=fundamental","pubTime":"2026-08-13 12:50","pubTimestamp":1786596641,"startTime":"0","endTime":"0","summary":"BofA Securities has released a report indicating that the Chinese CXO sector is poised to benefit from robust biotech venture capital funding. The bank notes that strong financing in the first half...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125910500.SGD","SMCO","SURI","LU0700851271.USD","IBRN","LU2328871848.SGD","CXO","LU0348766576.USD","BK1141","LU1979443071.USD","LU1303224171.USD","BK1576","LU1997245177.USD","LU1997244956.HKD","LU1046422090.SGD","LU1808992512.USD","LU0348767384.USD","LU2495084118.USD","161027","PSCH","APXH","LU0611395673.USD","PSIL","LU1934453819.USD","BBC","LU0456842615.SGD","IE00B543WZ88.USD","LU2488822045.USD","FHLC","IDNA","LU0320764599.SGD","WX","02359","MEDI","IE00BPRC5H50.USD","LU1770034418.SGD","BK1583","LU1997245094.SGD","BK0216","LU0052750758.USD","LFSC","LU2045819591.USD","LU1719994722.HKD","LU1969619763.USD","LU0708995583.HKD","IE00B5MMRT66.SGD","LU1251922891.USD","BMED","XBIX","LU2242644610.SGD","603259"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111112440","title":"Bank of America Securities Raises Targets for Chinese CXO Firms on Strong Biotech Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=1111112440","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111112440?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:35","pubTimestamp":1786588544,"startTime":"0","endTime":"0","summary":"A report from Bank of America Securities indicates that Chinese CRO/CDMO companies are poised to benefit from robust first-half funding in the global and Chinese biotech sectors, along with active...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0979878070.USD","APXH","LU1880383366.USD","LU1720050803.USD","PSCH","LU0039217434.USD","LU0359201612.USD","LU1046422090.SGD","LU0348766576.USD","WX","LU0052750758.USD","LU0516423174.USD","LU0823426480.USD","LU0359202008.SGD","LU1997245094.SGD","BK0216","LU1719994722.HKD","LU0611395673.USD","LU1997245177.USD","BK1610","LU1808992512.USD","02269","603259","LU0516423091.SGD","XBIX","BBC","LU1242518857.USD","LU0320764599.SGD","LU0588546209.SGD","LU2125910500.SGD","LU0348735423.USD","IE00BPRC5H50.USD","IE00B0JY6N72.USD","BK1583","IE00B543WZ88.USD","LU0140636845.USD","PSIL","IE00B5MMRT66.SGD","LU2039709279.SGD","SG9999002463.SGD","LU2495084118.USD","BK1521","LU0700851271.USD","LU0456842615.SGD","LU1251922891.USD","BK1576","LU0417516902.SGD","LU0456846285.SGD","LU2488822045.USD","LFSC","LU3063872942.SGD","BMED","LU1770034418.SGD","LU0307460666.USD","LU1303224171.USD","LU0327786744.USD","LU0051755006.USD","LU1794554557.SGD","IDNA","BK1589","LU0417516738.SGD","LU0326950275.SGD","LU0181495838.USD","LU0708995583.HKD","LU0856984785.SGD","LU1688375341.USD","LU0456827905.SGD","LU0128526141.USD","LU0029874061.USD","LU2045819591.USD","FHLC","LU1979443071.USD","161027","LU0348825331.USD","LU1997244956.HKD","SURI","LU1969619763.USD","LU1242518931.SGD","MEDI","LU0572944931.SGD","KURE","CXO","LU0823426308.USD","LU0516422440.USD","SG9999002562.SGD","LU0043850808.USD","LU2242644610.SGD","LU1934453819.USD","SMCO","LU0516422366.SGD","LU0348767384.USD","02359","LU2328871848.SGD","LU0516422952.EUR","03759","LU0819121731.USD","IBRN","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658906555","title":"Alkermes Cuts Interest Spreads on $1.52 Billion Term Loan Facilities Via Credit Agreement Amendment","url":"https://stock-news.laohu8.com/highlight/detail?id=2658906555","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658906555?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:19","pubTimestamp":1786547988,"startTime":"0","endTime":"0","summary":"Alkermes cuts interest spreads on $1.52 billion term loan facilities via credit agreement amendmentAlkermes entered an amendment on Aug. 12, 2026 to its Feb. 12, 2026 credit agreement with JPMorgan Chase Bank.The deal covers senior secured term loan A of USD 745.31 million, due Feb. 12, 2031, and term loan B of USD 773.06 million, due Aug. 12, 2031.The amendment cuts the interest spread by 0.75% on the term loan A facility, 0.5% on the term loan B facility.Term loan A now prices at Term SOFR plus 1.75%-2.25%, or base rate plus 0.75%-1.25%, based on secured net leverage.Term loan B now prices at Term SOFR plus 2.25%, or base rate plus 1.25%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL3L5Jbs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2357305700.SGD","LU2106854487.HKD","LU1363072403.SGD","IBRN","TFNS","TRUF","FNCL","LU0211326755.USD","LU0345770993.USD","IYG","IE00BZ1G4Q59.USD","LU2552382132.HKD","ALKS","LU0211331839.USD","LU0234572021.USD","IXG","VFH","JPO","LU1496350502.SGD","LU1116320901.HKD","LU2456880835.USD","UYG","PSCH","LU2462157665.USD","LU0265550946.USD","FTXO","IYF","IE00BYXW3230.USD","LU2237443622.USD","LU1629891620.HKD","MEDX","XLF","LU1720051017.SGD","LU0208291251.USD","LU1551013425.SGD","LU2054465674.USD","LU2505996681.GBP","LU0320765489.SGD","LU0320765646.SGD","LU0496365809.HKD","LU1974910355.USD","LU1162221912.USD","PSIL","LU0106261372.USD","FBT","LU2552382215.SGD","LU2023250843.SGD","KBWB","JPMO","JPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908840","title":"Alkermes - Enters Amendment No. 1 to Credit Agreement on August 12, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908840","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908840?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:27","pubTimestamp":1786541257,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4491BU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","BK4139","ALKS","PSIL","PSCH","FBT","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908808","title":"Alkermes - Amendment Reduces Interest Rate Spread Under Tla by 0.75% and Tlb by 0.50% - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908808?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:27","pubTimestamp":1786541257,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4491BU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","BK4139","ALKS","PSIL","PSCH","FBT","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107826889","title":"Jiangxi Party Chief Inspects Ganjiang New Area, Urges Accelerated Industry Transformation and New Growth Drivers","url":"https://stock-news.laohu8.com/highlight/detail?id=1107826889","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107826889?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:40","pubTimestamp":1786538436,"startTime":"0","endTime":"0","summary":"A provincial official, Yin Hong, visited the Ganjiang New Area on August 12, emphasizing the need to fully implement the spirit of the 15th Provincial Committee's 10th Plenary Session. He urged the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178440125","title":"Yin Hong Inspects Ganjiang New Area: Striving to Seize New Industrial Frontiers, Forge New Growth Drivers, and Demonstrate Excellence","url":"https://stock-news.laohu8.com/highlight/detail?id=1178440125","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178440125?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:01","pubTimestamp":1786536063,"startTime":"0","endTime":"0","summary":"On August 12, Yin Hong, Secretary of the Provincial Party Committee, conducted an in-depth inspection of the Ganjiang New Area. He emphasized the need to fully implement the spirit of the 15th...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136280436","title":"PICC P&C Issues China's First Invasive Brain-Computer Interface Surgery Accident Insurance","url":"https://stock-news.laohu8.com/highlight/detail?id=1136280436","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136280436?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:08","pubTimestamp":1786504105,"startTime":"0","endTime":"0","summary":"On August 12, PICC Property and Casualty Company Limited, a subsidiary of People's Insurance Company (Group) of China Limited (01339), announced it has underwritten the country's first invasive...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658468579","title":"Dianthus Therapeutics SVP General Counsel Adam Veness Melepas Saham Senilai USD 2,21 Juta","url":"https://stock-news.laohu8.com/highlight/detail?id=2658468579","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658468579?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:09","pubTimestamp":1786482556,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics SVP General Counsel Adam Veness melepas saham senilai USD 2,21 jutaSVP, General Counsel dan Secretary Adam M Veness melepas seluruh kepemilikan saham biasa Dianthus Therapeutics.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL4W8dyv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Dianthus Therapeutics SVP General Counsel Adam Veness Melepas Saham Senilai USD 2,21 Juta","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DNTH","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658343990","title":"J.P. Morgan Remains a Buy on Xenon (XENE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658343990","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658343990?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:56","pubTimestamp":1786449382,"startTime":"0","endTime":"0","summary":"In a report released today, Tessa Romero from J.P. Morgan maintained a Buy rating on Xenon, with a price target of $82.00. Romero covers the Health...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1732800096.USD","LU2357305700.SGD","LU0225283273.USD","LU1363072403.SGD","LU0053666078.USD","IAI","LU1548497426.USD","BK4534","IBRN","LU1791710400.SGD","LU0098860793.USD","LU1074936037.SGD","LU2023251221.USD","BK4588","LU1720051108.HKD","SBIO","LU0795875169.SGD","LU0158827781.USD","LU2089284900.SGD","LU2264538146.SGD","BK4139","LU0971096721.USD","LU1244550494.USD","LU0106831901.USD","LU1791710582.SGD","XENE","LU1244550221.USD","LU0210528500.USD","LU0795875086.SGD","LU2133065610.SGD","IE00B775SV38.USD","LU1720051017.SGD","LU0882574139.USD","LU0912757837.SGD","LU2271345857.HKD","BK4516","LU2089283258.USD","LU0320765646.SGD","IE00B3S45H60.SGD","LU1732799900.SGD","LU0314104364.USD","LU0390134368.USD","LU1989772923.USD","LU0106261372.USD","LU0234570918.USD","LU1244550577.SGD","LU2028103732.USD","LU1668664300.SGD","KBWB","LU1064131342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658966867","title":"Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), Elanco Animal Health (ELAN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658966867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658966867?lang=en_us&edition=fundamental","pubTime":"2026-08-11 10:20","pubTimestamp":1786414812,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dianthus Therapeutics (DNTH), Elanco Animal Health (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dianthus-therapeutics-dnth-elanco-animal-health-elan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dianthus-therapeutics-dnth-elanco-animal-health-elan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU0128526141.USD","BK4007","IBRN","BK4588","BK4139","BK4137","BK4585","LABU","LU1941712348.USD","BK4561","DNTH","LU1941712264.USD","XLV","ELAN","BK4581","XBI","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939006","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658939006?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:50","pubTimestamp":1786366208,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS) and Dianthus Therapeutic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-dianthus-therapeutics-dnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-dianthus-therapeutics-dnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","GLAM","BK4139","IBRN","HMYY","THNR","HIYY","HEAL","HIMS","HIMZ","HIMY","DNTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658987680","title":"Scholar Rock Holding Price Target Maintained with a $65.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2658987680","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658987680?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:14","pubTimestamp":1786356840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SRRK/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THNR","IBRN","SRRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658982377","title":"Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Relay Therapeutics (RLAY) and Amylyx Pharmaceuticals Inc (AMLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658982377","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658982377?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:40","pubTimestamp":1786354831,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Xenon (XENE), Relay Therapeutics (RLAY) and Amylyx P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-xenon-xene-relay-therapeutics-rlay-and-amylyx-pharmaceuticals-inc-amlx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-xenon-xene-relay-therapeutics-rlay-and-amylyx-pharmaceuticals-inc-amlx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","SBIO","LU0128526141.USD","XLV","HCSG","LABU","IBRN","LU0029874061.USD","BK4137","RLAY","BK4585","BK4139","XENE","BK4563","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658347984","title":"Update: Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2658347984","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658347984?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:19","pubTimestamp":1786353580,"startTime":"0","endTime":"0","summary":"(Updates with day of announcement in first paragraph, Novo Nordisk's affiliation in the second paragraph, and latest stock moves in the fourth paragraph.)Scholar Rock Holding (SRRK) said Friday that t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SRRK","BK4139","IBRN","THNR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}